Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02148042 · ClinicalTrials.gov registry record

Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
26
Enrollment target

NCT02148042: Completed study, sponsored by University of Minnesota.

NCT02148042 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02148042 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

Anorexia nervosa is a chronic mental health condition characterized by maladaptive food consumption (i.e., hypophagia) and distorted body image. There is substantial evidence of a phenotypic overlap between anorexia nervosa and anxiety disorders, as well as data suggesting the two share a common genetic pathway. Despite these findings, little research has examined fear conditioning among individuals with anorexia nervosa, and no research has examined whether individuals with anorexia nervosa have a propensity to overgeneralize conditioned fear stimuli, one of the more robust fear-conditioning markers of anxiety disorders. The current study assesses generalization of conditioned fear with fear-potentiated startle: the cross-species enhancement of the startle reflex when an organism is in a state of fear. Animal data, as well as an emerging literature in humans, tightly links fear-potentiated startle to the amygdala-based fear circuit. Thus, evidence of overgeneralized fear-potentiated startle in anorexia nervosa would link this eating disorder to hypersensitivity of the fear circuit and could inform the development of novel pharmacologic and psychological treatments for anorexia nervosa based on treatment models used in the anxiety disorders literature.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2014-04
Est. Completion 2016-07
University of Minnesota

966 total trials

What the finished NCT02148042 record still lists

NCT02148042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02148042 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02148042 about?

NCT02148042 is a clinical study titled "Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa". Anorexia nervosa is a chronic mental health condition characterized by maladaptive food consumption (i.e., hypophagia) and distorted body image. There is substantial evidence of a phenotypic overlap between anorexia nervosa and anxiety disorders, as well as data suggesting the two share a common gen...

What is the current status of trial NCT02148042?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-04. Estimated completion is 2016-07.

Who is sponsoring clinical trial NCT02148042?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02148042, the US trial registry maintained by the National Library of Medicine. NCT02148042 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.